Samsara BioCapital, LLC
- SEC CIK
- 0001744967
- Latest filing
- Aug 14, 2026
MLYS holding history
Mineralys Therapeutics, Inc. in every 13F filed by Samsara BioCapital, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
MLYS overviewAll 13F holders of MLYSFull Q2 2026 holdings
- Shares (Q2 2026)
- 5,871,018
- Value
- $158.4M
- % of portfolio
- 13.0%
- Quarters held
- 14
- Since Q1 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 5,871,018 | $158.4M | 13.0% | 00.0% | Unchanged | Holders |
| Q1 2026 | 5,871,018 | $159.0M | 15.5% | 00.0% | Unchanged | Holders |
| Q4 2025 | 5,871,018 | $213.1M | 22.0% | −392,133−6.3% | Reduced | Holders |
| Q3 2025 | 6,263,151 | $237.5M | 31.0% | +588,235+10.4% | Added | Holders |
| Q2 2025 | 5,674,916 | $76.8M | 15.7% | 00.0% | Unchanged | Holders |
| Q1 2025 | 5,674,916 | $90.1M | 16.1% | +600,000+11.8% | Added | Holders |
| Q4 2024 | 5,074,916 | $62.5M | 8.6% | 00.0% | Unchanged | Holders |
| Q3 2024 | 5,074,916 | $61.5M | 11.8% | 00.0% | Unchanged | Holders |
| Q2 2024 | 5,074,916 | $59.4M | 12.4% | 00.0% | Unchanged | Holders |
| Q1 2024 | 5,074,916 | $65.5M | 10.1% | +555,555+12.3% | Added | Holders |
| Q4 2023 | 4,519,361 | $38.9M | 6.0% | 00.0% | Unchanged | Holders |
| Q3 2023 | 4,519,361 | $43.0M | 13.2% | 00.0% | Unchanged | Holders |
| Q2 2023 | 4,519,361 | $77.1M | 13.5% | 00.0% | Unchanged | Holders |
| Q1 2023 | 4,519,361 | $70.8M | 14.6% | +4,519,361 | New | Holders |